The issue of light pollution has garnered increased attention recently,largely due to the widespread use of electronic devices.Blue light(BL)holds the highest energy level among visible light and has been extensively ...The issue of light pollution has garnered increased attention recently,largely due to the widespread use of electronic devices.Blue light(BL)holds the highest energy level among visible light and has been extensively researched for its potential to cause damage to the retina.Ferroptosis,a recently identified form of programmed cell death form,has been linked to retinal diseases.However,the connection between BL-induced retinal damage and ferroptosis remains elusive.This study aims to investigate the involvement of ferroptosis in retinal damage under BL exposure and its underlying mechanism.In this study,a mouse retinal damage model and cultured ARPE-19 cells exposed to BL were employed.Various techniques including Haematoxylin-eosin staining,fundus photography,immunostaining,and transmission electron microscopywere employed to examine retinal structure and morphology changes resulting from BL exposure.To identify ferroptosis levels in vitro,we employed DCFH-DA,C11-BODIPY 581/591,and FeRhoNox^(TM)-1 probes.Additionally,real-time PCR and western blotting techniques were used to uncover potential targets in BL-induced ferroptosis.Our study showed that BL exposure can result in iron overload,oxidative stress,evidenced by increased markers TFR1,ACSL4,HO-1 and decreased expression level of SOD2,CAT and ferroptosis-associated gene of GPX4.Interestingly,we found that Deferoxamine mesylate,a compound capable of chelating excess Fe2+caused by BL,effectively mitigated lipid peroxidation,and alleviated retinal damage both in vivo and in vitro.The discoveries will advance our knowledge of BL-induced retinal damage.展开更多
The aim of our study was to evaluate the clinical efficacy of m FOLFOX-HAIC combined with donafenib and sintilimab conversion therapy followed by surgical resection of large hepatocellular carcinoma with portal vein t...The aim of our study was to evaluate the clinical efficacy of m FOLFOX-HAIC combined with donafenib and sintilimab conversion therapy followed by surgical resection of large hepatocellular carcinoma with portal vein tumor thrombus(PVTT).The clinical data of two patients with large hepatocellular carcinoma who were admitted to the Second Affiliated Hospital of Kunming Medical University were retrospectively collected.Both patients received m FOLFOX-HAIC combined with donafenib and sintilimab conversion therapy,followed by hepatectomy.Clinical data were reported,and clinical efficacy was evaluated.One patient had a 14.5×11.1 cm tumor with a tumor thrombus in the right portal vein.The other patient had a 12.1×8.3 cm tumor with portal and hepatic vein tumor thrombi.Both patients had CNLC stageⅢa prior to conversion therapy,which was reduced to stageⅠb after conversion therapy.Subsequently,the patient underwent open and laparoscopic right hemihepatectomies.Short-term high-intensity conversion therapy with m FOLFOXHAIC combined with donafenib and sintilimab is a feasible and effective treatment for patients with large hepatocellular carcinoma with PVTT.展开更多
基金supported by the Strategic Priority Research Program of Chinese Academy of Sciences(No.XDA16040200)the National Nature Science Foundation of China(Nos.82201194 and 82371084).
文摘The issue of light pollution has garnered increased attention recently,largely due to the widespread use of electronic devices.Blue light(BL)holds the highest energy level among visible light and has been extensively researched for its potential to cause damage to the retina.Ferroptosis,a recently identified form of programmed cell death form,has been linked to retinal diseases.However,the connection between BL-induced retinal damage and ferroptosis remains elusive.This study aims to investigate the involvement of ferroptosis in retinal damage under BL exposure and its underlying mechanism.In this study,a mouse retinal damage model and cultured ARPE-19 cells exposed to BL were employed.Various techniques including Haematoxylin-eosin staining,fundus photography,immunostaining,and transmission electron microscopywere employed to examine retinal structure and morphology changes resulting from BL exposure.To identify ferroptosis levels in vitro,we employed DCFH-DA,C11-BODIPY 581/591,and FeRhoNox^(TM)-1 probes.Additionally,real-time PCR and western blotting techniques were used to uncover potential targets in BL-induced ferroptosis.Our study showed that BL exposure can result in iron overload,oxidative stress,evidenced by increased markers TFR1,ACSL4,HO-1 and decreased expression level of SOD2,CAT and ferroptosis-associated gene of GPX4.Interestingly,we found that Deferoxamine mesylate,a compound capable of chelating excess Fe2+caused by BL,effectively mitigated lipid peroxidation,and alleviated retinal damage both in vivo and in vitro.The discoveries will advance our knowledge of BL-induced retinal damage.
基金Supported by grants from the Clinical Research Program of Kunming Medical University(No.yn IIT20211013)the Joint Special Fund Project of Kunming Medical University(No.202201AY070001-105)。
文摘The aim of our study was to evaluate the clinical efficacy of m FOLFOX-HAIC combined with donafenib and sintilimab conversion therapy followed by surgical resection of large hepatocellular carcinoma with portal vein tumor thrombus(PVTT).The clinical data of two patients with large hepatocellular carcinoma who were admitted to the Second Affiliated Hospital of Kunming Medical University were retrospectively collected.Both patients received m FOLFOX-HAIC combined with donafenib and sintilimab conversion therapy,followed by hepatectomy.Clinical data were reported,and clinical efficacy was evaluated.One patient had a 14.5×11.1 cm tumor with a tumor thrombus in the right portal vein.The other patient had a 12.1×8.3 cm tumor with portal and hepatic vein tumor thrombi.Both patients had CNLC stageⅢa prior to conversion therapy,which was reduced to stageⅠb after conversion therapy.Subsequently,the patient underwent open and laparoscopic right hemihepatectomies.Short-term high-intensity conversion therapy with m FOLFOXHAIC combined with donafenib and sintilimab is a feasible and effective treatment for patients with large hepatocellular carcinoma with PVTT.
